These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 10748866)

  • 1. Decreased metastatic spread in mice homozygous for a null allele of the cystatin C protease inhibitor gene.
    Huh CG; Håkansson K; Nathanson CM; Thorgeirsson UP; Jonsson N; Grubb A; Abrahamson M; Karlsson S
    Mol Pathol; 1999 Dec; 52(6):332-40. PubMed ID: 10748866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of B16 melanoma metastasis by overexpression of the cysteine proteinase inhibitor cystatin C.
    Cox JL; Sexton PS; Green TJ; Darmani NA
    Melanoma Res; 1999 Aug; 9(4):369-74. PubMed ID: 10504055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice.
    Bengtsson E; To F; Håkansson K; Grubb A; Brånén L; Nilsson J; Jovinge S
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2151-6. PubMed ID: 16051881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystatin C takes part in melanoma-microglia cross-talk: possible implications for brain metastasis.
    Moshe A; Izraely S; Sagi-Assif O; Prakash R; Telerman A; Meshel T; Carmichael T; Witz IP
    Clin Exp Metastasis; 2018 Aug; 35(5-6):369-378. PubMed ID: 29722001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of the protease inhibitor cystatin C in inflammatory cells results in larger plaque area in plaque regression of apoE-deficient mice.
    Bengtsson E; To F; Grubb A; Håkansson K; Wittgren L; Nilsson J; Jovinge S
    Atherosclerosis; 2005 May; 180(1):45-53. PubMed ID: 15823274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of experimental human fibrosarcoma lung metastasis in mice by adenovirus-mediated cystatin C overexpression in the host.
    Kopitz C; Anton M; Gansbacher B; Krüger A
    Cancer Res; 2005 Oct; 65(19):8608-12. PubMed ID: 16204025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice.
    Pennacchio LA; Bouley DM; Higgins KM; Scott MP; Noebels JL; Myers RM
    Nat Genet; 1998 Nov; 20(3):251-8. PubMed ID: 9806543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of B16 melanoma lung colonization by syngeneic monoclonal antibodies.
    Herd ZL
    Cancer Res; 1987 May; 47(10):2696-703. PubMed ID: 3552203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of mouse melanoma cell lines by their mortal malignancy using an experimental metastatic model.
    Nakamura K; Yoshikawa N; Yamaguchi Y; Kagota S; Shinozuka K; Kunitomo M
    Life Sci; 2002 Jan; 70(7):791-8. PubMed ID: 11833741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystatins--Extra- and intracellular cysteine protease inhibitors: High-level secretion and uptake of cystatin C in human neuroblastoma cells.
    Wallin H; Bjarnadottir M; Vogel LK; Wassélius J; Ekström U; Abrahamson M
    Biochimie; 2010 Nov; 92(11):1625-34. PubMed ID: 20800088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystatins--inhibitors of cysteine proteinases.
    Bobek LA; Levine MJ
    Crit Rev Oral Biol Med; 1992; 3(4):307-32. PubMed ID: 1391414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1.
    Khokha R
    J Natl Cancer Inst; 1994 Feb; 86(4):299-304. PubMed ID: 8158685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of motility and invasion of B16 melanoma by the overexpression of cystatin C.
    Sexton PS; Cox JL
    Melanoma Res; 1997 Apr; 7(2):97-101. PubMed ID: 9167174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epilepsy. Protease inhibitor implicated.
    McNamara JO; Puranam RS
    Nature; 1996 May; 381(6577):26-7. PubMed ID: 8609982
    [No Abstract]   [Full Text] [Related]  

  • 15. Extraction of immunogenic and suppressogenic antigens from variants of B16 melanoma exhibiting low or high metastatic potentials.
    LeGrue SJ; Hearn DR
    Cancer Res; 1983 Nov; 43(11):5106-11. PubMed ID: 6616449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organ selectivity for implantation survival and growth of B16 melanoma variant tumor lines.
    Fidler IJ; Nicolson GL
    J Natl Cancer Inst; 1976 Nov; 57(5):1199-202. PubMed ID: 1003551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the cysteine proteinase inhibitor cystatin C gene in rat heart: use of digoxigenin-labeled probes generated by polymerase chain reaction directly for in situ and northern blot hybridizations.
    Barka T; van der Noen H
    J Histochem Cytochem; 1993 Dec; 41(12):1863-7. PubMed ID: 8245434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of glial development by cystatin C.
    Hasegawa A; Naruse M; Hitoshi S; Iwasaki Y; Takebayashi H; Ikenaka K
    J Neurochem; 2007 Jan; 100(1):12-22. PubMed ID: 17064358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards novel anti-cancer strategies based on cystatin function.
    Keppler D
    Cancer Lett; 2006 Apr; 235(2):159-76. PubMed ID: 15893421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammalian cystatin and protagonists in brain diseases.
    Amin F; Khan MS; Bano B
    J Biomol Struct Dyn; 2020 Apr; 38(7):2171-2196. PubMed ID: 31107181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.